COMMUNIQUÉS West-GlobeNewswire

Sevaro Health Named to the 2025 CB Insights’ List of the 50 Most Promising Digital Health Startups
28/10/2025
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- CB Insights named Sevaro Health to its seventh annual Digital Health 50, showcasing the 50 most promising private digital health companies in the world. “The 2025 Digital [...]
Olympia Pharmaceuticals Strengthens National Presence, Bringing New Licensing to Mississippi
28/10/2025
The industry-leading 503B outsourcing facility grows its footprint to 49 states, offering expanded healthcare resources with a spotlight on Mississippi ORLANDO, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Olympia [...]
New Study Finds Online Tinnitus Course “Still Tinnitus” Effective
28/10/2025
Independent research shows that the self-paced “Still Tinnitus” course can help reduce tinnitus symptoms and improve quality of life for people with tinnitus worldwide. Amsterdam, The Netherlands, Oct. 28, 2025 (GLOBE [...]
Assertio Announces Leadership Transition
28/10/2025
Appoints Industry Veteran and Current Director Mark L. Reisenauer as CEO, Effective Immediately Company Will Report Third Quarter Results on November 10, 2025 and Expects to Update Guidance Within the Current Range at [...]
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
28/10/2025
MIAMI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, [...]
Novartis completes acquisition of Tourmaline Bio
28/10/2025
Basel, October 28, 2025 - Novartis today announced that it has successfully completed its acquisition of Tourmaline Bio, Inc. (“Tourmaline”). With the completion of the acquisition, shares of common stock, par value $0. [...]
Trethera Successfully Completes Phase 1 Dose Escalation Trial Demonstrating Broad Therapeutic Window, Favorable Safety, and Confirmed Target Engagement
28/10/2025
LOS ANGELES, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, today announced [...]
Remedy's Nutrition® Launches Premium Horse Chestnut 1000mg Capsules to Support Vein Health and Healthy Circulation
28/10/2025
KEY LARGO, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Remedy's Nutrition®, a trusted natural dietary supplement company since 1972 and a leader in premium herbal formulations, today announced the launch of its high-potency [...]
Former Amazon Care Executive Dr. Sunita Mishra Joins Heald’s Advisory Board to Accelerate Expansion Across Employers and Provider Networks
28/10/2025
ALPHARETTA, Ga., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Heald , the human-led, tech-enabled platform redefining Diabetes care, proudly announces that Dr. Sunita Mishra, former Chief Medical Officer of Amazon Health services [...]
Curia Releases 2024 Environmental, Social and Governance (ESG) Report
28/10/2025
ALBANY, N.Y., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced the release of its third Environmental, Social and [...]
Zymeworks Announces Participation in Upcoming Investor Conferences
28/10/2025
VANCOUVER, British Columbia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the [...]
Orion Group Interim Report January–September 2025
28/10/2025
ORION CORPORATION INTERIM REPORT 1–9/2025 28 OCTOBER 2025 at 12:00 EET Orion Group Interim Report January–September 2025 July–September 2025 Highlights Net sales totalled EUR 423.2 (July–September 2024: 471.3) million [...]
Upgrade of guidance
28/10/2025
ANNOUNCEMENT NO. 295 28 October 2025 Upgrade of guidance ChemoMetec experiences an increased interest in its technology, not the least the XcytoMatic platform, and consequently expects a positive trend in revenue and [...]
PL BioScience Announces new Board Member Ole Henrik Bang-Andreasen
28/10/2025
AACHEN, Germany, Oct. 28, 2025 (GLOBE NEWSWIRE) -- PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion and manufacturing, [...]
Regeneron Reports Third Quarter 2025 Financial and Operating Results
28/10/2025
Third quarter 2025 revenues increased 1% to $3.75 billion versus third quarter 2024 Dupixent ® global net sales (recorded by Sanofi) increased 27% to $4.86 billion EYLEA HD ® U.S. net sales increased 10% to $431 million [...]
KFSHRC inaugure la première usine de fabrication de thérapies géniques et cellulaires en Arabie saoudite
28/10/2025
RIYAD, Arabie saoudite, 28 oct. 2025 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre a annoncé qu’il ouvrirait la première usine d’Arabie saoudite pour la fabrication de thérapies génétiques [...]
Amphista Therapeutics to showcase how its Targeted Glue™ technology is expanding the diversity of TPD medicines at the 8th Annual TPD & Induced Proximity Summit 2025
28/10/2025
Presentation will showcase the novel mechanisms of degradation of Amphista's Targeted Glues™, which recruit diverse E3 ligases, including DCAF16 and FBXO22, expanding the diversity and opportunity for TPD medicines. The [...]
AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board
28/10/2025
AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board Brings substantial expertise in development of first-in-class disease-modifying therapies in dementia across multiple novel [...]
Tonix Pharmaceuticals Announces Presentation at BIO-Europe 2025
28/10/2025
CHATHAM, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial biopharmaceutical company announced today that Seth Lederman [...]

Pages